Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sasmar Pharmaceuticals has acquired US-based Aquatrove Biosciences for an undisclosed sum to strengthen its over-the-counter product portfolio.
Subscribe to our email newsletter
Aquatrove is a Chicago based biotechnology company with focus on human reproductive health and fertility products.
Through the deal, the Brussels, Belgium headquartered company will acquire Aquatrove’s international portfolio consisting of intellectual property, patents and research data.
Sasmar president and CEO John-Michael Mancini said: "The acquisition captures the capability and knowhow built up over many years by the specialized team at Aquatrove and facilitates the realization of our plans for growth moving forward."
The two companies were associated before as Sasmar commercialized a patented pregnancy-increasing formulation developed by Aquatrove in 2008.
The formulation which contained calcium and magnesium ions was manufactured as a fertility lubricant.
It is being marketed internationally under the brand Conceive Plus which can be used to increase chances of a natural pregnancy in place of regular personal lubricant used with sexual intercourse during ovulation.
In the US, Sasmar had received FDA clearance for the fertility lubricant towards the end of 2013. The brand is planned to be launched in major US drug stores from next month.
Aquatrove was co-founded in 2005 in Boston by faculty members from Harvard Medical School and the Massachusetts General Hospital.
Samsar claimed to supply personal lubricants to the United Nations as well as international NGOs.
The lubricants are distributed by these organizations to serve their objective of reducing unwanted pregnancies and sexually transmitted diseases that include HIV/AIDS.